Rigel Pharmaceuticals
RIGL
RIGL
126 hedge funds and large institutions have $234M invested in Rigel Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 35 increasing their positions, 48 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
126
Holders Change
-10
Holders Change %
-7.35%
% of All Funds
2.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
35
Reduced
48
Closed
17
Calls
$48K
Puts
$51K
Net Calls
-$3K
Net Calls Change
+$70K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Ameriprise
Minneapolis,
Minnesota
| – | -$158K | -7,383 | Closed |
|
|
WG
127
Winton Group
London,
United Kingdom
| – | -$113K | -5,262 | Closed |
|
|
CG
128
Caprock Group
Boise,
Idaho
| – | -$42K | -1,960 | Closed |
|
|
XM
129
XTX Markets
New York
| – | -$32K | -1,496 | Closed |
|
|
FDCDDQ
130
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$31.2K | -1,462 | Closed |
|
|
GIP
131
Granite Investment Partners
El Segundo,
California
| – | -$31K | -1,430 | Closed |
|
132
LPL Financial
San Diego,
California
| – | -$25K | -1,150 | Closed |
|
|
PP
133
Paloma Partners
Greenwich,
Connecticut
| – | -$24K | -1,133 | Closed |
|
|
ECM
134
ExodusPoint Capital Management
New York
| – | -$24K | -1,112 | Closed |
|
|
HF
135
HRT Financial
New York
| – | -$23K | -1,104 | Closed |
|
136
Lazard Asset Management
New York
| – | -$15K | -735 | Closed |
|
|
PCM
137
Prelude Capital Management
New York
| – | -$10K | -476 | Closed |
|
|
NFG
138
Next Financial Group
Houston,
Texas
| – | -$5K | -245 | Closed |
|